红花的抗肿瘤作用研究进展
Research Progress on Anti-Tumor Effect of Safflower
摘要: 随着恶性肿瘤发生率的日趋增高，恶性肿瘤已成为危害人类健康的主要疾病之一。红花(Safflower)是一种菊科草本植物，我国传统医学很早便将红花用于治疗疾病，《本草纲目》记载其可“活血、润燥、止痛、散肿、通经”。近年来多项实验对红花的药理作用及机制进行了深入研究，发现红花除具有心肌保护、降血压、抗血小板聚合、抗血栓生成、抗动脉粥样硬化等作用外，还表现出不可忽视的抗肿瘤作用。本综述主要探讨红花及其活性成分的抗肿瘤机制及研究进展。以期为后续的临床应用提供科学依据。
Abstract: With the increasing incidence of malignant tumors, malignant tumors have become one of the main diseases that endanger human health. Safflower is a Compositae herb. Safflower has been used in the treatment of diseases in traditional Chinese medicine for a long time, and the “Materia Medica Outline” records that it can promote blood circulation, moisturize dryness, relieve pain, disperse swelling and dredge meridians. In recent years, a number of experiments have conducted in-depth research on the pharmacological effects and mechanisms of safflower. It has been found that safflower not only has the effects of myocardial protection, lowering blood pressure, anti-platelet aggregation, anti-thrombosis, and anti-atherosclerosis, but also has anti-tumor effects that cannot be ignored. This review mainly discusses the anti-tumor mechanism and research progress of safflower and its active components, in order to provide scientific basis for subsequent clinical application.
文章引用：李倩, 刘长民. 红花的抗肿瘤作用研究进展[J]. 临床医学进展, 2022, 12(1): 394-398. https://doi.org/10.12677/ACM.2022.121059

参考文献

[1] Li, J., Zhang, S., Lu, M., et al. (2013) Hydroxysafflor Yellow A Suppresses Inflammatory Responses of BV2 Microglia after Oxygen-Glucose Deprivation. Neuroscience Letters, 535, 51-56. [Google Scholar] [CrossRef] [PubMed]
[2] Yang, F., Li, J., Zhu, J., Wang, D., Chen, S. and Bai, X. (2015) Hydroxysafflor Yellow A Inhibits Angiogenesis of Hepatocellular Carcinoma via Blocking ERK/MAPK and NF-κB Signaling Pathway in H22 Tumor-Bearing Mice. European Journal of Pharmacology, 754, 105-114. [Google Scholar] [CrossRef] [PubMed]
[3] Chen, T.T., Du, Y.J., Liu, X.L. and Zhu, H.B. (2008) Inhibitory Action of Hydroxysafflor Yellow A on Inflammatory Signal Transduction Pathway Related Factors in Rats with Cerebral Cortex Ischemia. Acta pharmaceutica Sinica, 43, 570-575.
[4] 张前, 牛欣, 闫妍, 等. 羟基红花黄色素A抑制新生血管形成的机制研究[J]. 北京中医药大学学报, 2004, 27(3): 25-29. [Google Scholar] [CrossRef] 
[5] Xi, S.Y., Zhang, Q., Liu, C.Y., Xie, H., Yue, L.F. and Gao, X.M. (2012) Effects of Hydroxy Safflower Yellow-A on Tumor Capillary Angiogenesis in Transplanted Human Gastric Adenocarcinoma BGC-823 Tumors in Nude Mice. Journal of Traditional Chinese Medicine, 32, 243-248. [Google Scholar] [CrossRef] 
[6] Wang, J., Wang, J., Wang, X., et al. (2016) Molecular Mechanism of Inhibition of the Abnormal Proliferation of Human Umbilical Vein Endothelial Cells by Hydroxysafflor-Yellow A. Pharmaceutical Biology, 54, 1800-1807. [Google Scholar] [CrossRef] [PubMed]
[7] Zhang, J., Li, J., Song, H., Xiong, Y., Liu, D. and Bai, X. (2019) Hydroxysafflor Yellow A Suppresses Angiogenesis of Hepatocellular Carcinoma through Inhibition of p38 MAPK Phosphorylation. Biomedicine & Pharmacotherapy, 109, 806-814. [Google Scholar] [CrossRef] [PubMed]
[8] Liu, L., Si, N., Ma, Y., et al. (2018) Hydroxysafflor-Yellow A Induces Human Gastric Carcinoma BGC-823 Cell Apoptosis by Activating Peroxisome Proliferator-Activated Receptor Gamma (PPARγ). Medical Science Monitor, 24, 803-811. [Google Scholar] [CrossRef] 
[9] Ma, Y., Feng, C., Wang, J., et al. (2019) Hydroxyl Safflower Yellow A Regulates the Tumor Immune Microenvironment to Produce an Anticancer Effect in a Mouse Model of Hepatocellular Carcinoma. Oncology Letters, 17, 3503-3510. [Google Scholar] [CrossRef] [PubMed]
[10] Jackson, D.N. and Theiss, A.L. (2020) Gut Bacteria Signaling to Mitochondria in Intestinal Inflammation and Cancer. Gut Microbes, 11, 285-304. [Google Scholar] [CrossRef] [PubMed]
[11] 曾普华. 从炎性微环境探析肿瘤恶液质的“癌毒致虚”病机观[J]. 陕西中医, 2021, 42(8): 987-990+1137.
[12] Jiang, M., Zhou, L.Y., Xu, N. and An, Q. (2019) Hydroxysafflor Yellow A Inhibited Lipopolysaccharide-Induced Non-Small Cell Lung Cancer Cell Proliferation, Migration, and Invasion by Suppressing the PI3K/AKT/mTOR and ERK/MAPK Signaling Pathways. Thoracic Cancer, 10, 1319-1333. [Google Scholar] [CrossRef] [PubMed]
[13] Pan, Y., Yu, Y., Wang, X. and Zhang, T. (2020) Tumor-Associated Macrophages in Tumor Immunity. Frontiers in Immunology, 11, Article ID: 583084. [Google Scholar] [CrossRef] [PubMed]
[14] Wang, Q., Huang, Y., Jia, M., et al. (2021) Safflower Polysaccharide Inhibits AOM/DSS-Induced Mice Colorectal Cancer through the Regulation of Macrophage Polarization. Frontiers in Pharmacology, 12, Article ID: 761641. [Google Scholar] [CrossRef] [PubMed]
[15] Luo, Z., Zeng, H., Ye, Y., et al. (2015) Safflower Polysaccharide Inhibits the Proliferation and Metastasis of MCF-7 Breast Cancer Cell. Molecular Medicine Reports, 11, 4611-4616. [Google Scholar] [CrossRef] [PubMed]
[16] Leong, H.S., Robertson, A.E., Stoletov, K., et al. (2014) Invadopodia Are Required for Cancer Cell Extravasation and Are a Therapeutic Target for Metastasis. Cell Reports, 8, 1558-1570. [Google Scholar] [CrossRef] [PubMed]
[17] Fu, H., Wu, R., Li, Y., et al. (2016) Safflower Yellow Prevents Pulmonary Metastasis of Breast Cancer by Inhibiting Tumor Cell Invadopodia. The American Journal of Chinese Medicine, 44, 1491-1506. [Google Scholar] [CrossRef] 
[18] Lin, K., Qin, Z., Qu, C., et al. (2021) Hydroxyl Safflower Yellow B Combined with Doxorubicin Inhibits the Proliferation of Human Breast Cancer MCF-7 Cells. Oncology Letters, 21, 426. [Google Scholar] [CrossRef] [PubMed]
[19] Qu, C., Zhu, W., Dong, K., et al. (2019) Inhibitory Effect of Hydroxysafflor Yellow B on the Proliferation of Human Breast Cancer MCF-7 Cells. Recent Patents on Anti-Cancer Drug Discovery, 14, 187-197. [Google Scholar] [CrossRef] 

为你推荐